Good evening, this is Markets Desk with your closing bell briefing.
Democrats have delivered a sharp rebuke to President Trump, sweeping congressional races from Texas to Georgia and flipping control of Capitol Hill in what analysts are already calling a defining midterm result. The political shift carries real market implications, with fiscal and regulatory expectations now in flux heading into the back half of this administration.
Turning to corporate strategy, CVS Health is reportedly weighing a breakup of its healthcare empire, with a spin-off of its retail pharmacy operations under active consideration. The move would unwind years of vertical integration built around the Aetna acquisition, and investors are watching closely to see whether the market rewards a leaner structure or punishes the retreat from a unified healthcare model.
And in quantum computing, D-Wave is drawing fresh attention after customer Shionogi took top honors in October two thousand twenty six for quantum-assisted drug discovery research. With a new relationship announced alongside LG CNS, D-Wave is positioning itself as a commercial-stage player at a moment when the sector is hungry for real-world proof points beyond laboratory benchmarks.
That's the tape. Markets Desk, signing off the floor.
